A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma Meeting Abstract
| Authors: | Kang, H.; Ho, A. L.; Muzaffar, J.; Bowles, D. W.; Kim, S. B.; Ahn, M. J.; Hanna, G. J.; Worden, F. P.; Yun, T.; Norton, S.; Sankar, N.; Keam, B. |
| Abstract Title: | A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309210 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS6597 |
| Notes: | Meeting Abstract: TPS6597 -- Source: Wos |
